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Although epidemiologic data suggest a relation between 
myocardial infarction death rates and dietary intake of 
magnesium, there are no experimental studies reflecting 
such a phenomenon. It is now reported that beagle dogs 
kept on a severely magnesium-deficient diet for 100 days 
develop a larger infarct than do control animals. Control 
animals were either kept on the same diet as experi-
mental animals with supplementary magnesium, or were 
fed standard dog chow. The control groups were indis-
tinguishable and were therefore pooled. Infarction was 
produced by occlusion of the left anterior descending 
coronary artery for 1 hour followed by 4 hours of re-
perfusion. Slices of ventricular myocardium,S mm thick, 
were made from the apex to the base. Ischemic muscle, 
considered to be the muscle at risk, was delineated by 
a microsphere-autoradiographic method, and necrotic 
muscle was delineated by tetrazolium stain. Involved 
areas were measured by planimetry, and these inte-
grated to produce the volume. The volumes of muscle 
The association between water hardness and cardiovascular 
disease was first reported by Kobayashi (I). Subsequent 
ep\demiologic studies have repeatedly demonstrated an in-
verse relation between water hardness and sudden death 
(2,3). Neri arid Johansen (3) studied the epidemiologic as-
sociation of cardiovascular death rates and 13 ionic sub-
stances in drinking water. They found a higher degree of 
correlation for magnesium than for any other water con-
stituent. As anticipated from other studies, the correlation 
was inverse. Neri and Hewitt (4) used data collected by 
Anderson et al. (5,6) to show that the regression of relative 
risk of death by myocardial infarction on the myocardial 
magnesium concentration is also a good fit with a negative 
slope. 
Seelig (7) reviewed the data implicating magnesium de-
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made ischemic were similar in the experimental aQd con-
trol groups. The volumes of necrotic muscle, however, 
were less in the control than in the experimental animals. 
The ratio of necrotic muscle volume to tJle volume of 
muscle at risk was greater in the experimental animals 
than in the control animals by a factor of almost two 
(p < 0.004). 
These experiments indicate that, under the conditions 
used here, animals fed a magnesium-deficient diet de-
velop a larger infarct than do control animals. This could 
occur either through decreased postocclusion collateral 
flow or increased vulnerability of the ischemic muscle in 
magnesium-deficient animals. Although these experi-
ments cannot rule out an effect on postocclusion collat-
eral flow, they do suggest that electrolyte abnormalities 
related to magnesium deficiency are of such a character 
as to increase myocardial vulnerability to injury. 
(J Am Coli CardioI1985;5:280-9) 
ficiency in the pathogenesis of myocardial infarction as well 
as data and theories attempting to explain this relation. It 
has been pointed out that magnesium deficiency may in-
crease the severity of atherosclerosis (8), likelihood of coro-
nary artery spasm (9-13) and vulnerability to arrhythmia 
(14-16). It is also possible that magnesium deficiency af-
fects infarct size, but this possibility has not been examined 
experimentally. The purpose of the experiments described 
here was to determine whether dietary magnesium defi-
ciency would influence the size of myocarc\ial infarcts 
produced by experimental coronary artery occlusion. 
Methods 
Animal maintenance. Thirteen mature beagle dogs, five 
female and eight male, were obtained from the Hazelton 
Research Laboratory. Their average age was 18 months. 
They were housed in individual stainless steel cages. All 
dogs were given 400 g of feed per day. Deionized water 
(resistivity> 12 MH) was continuously available. The eight 
male dogs were fed a semisynthetic diet (Table I) that was 
nutritionally adequate, except that it contained no added 
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Table 1. Composition of Magnesium-Deficient Diet for Dogs 
Casein 
Sucrose 
Corn starch 
Lard 
Com oil 
Ingredient 
Fiber (cellulose) 
Mineral mix, magnesium-deficient* 
Calcium phosphate* 
Sodium chloride* 
Vitamin mix 
g/kg 
240 
4n.5 
100.0 
40.0 
20.0 
20.0 
no 
9.2 
5.2 
IO.R 
* All chemicals used in the diet mixture were analytical reagent grade. 
The "magnesium-deficient mineral mix" contained, in percent units (w/w): 
calcium phosphate, dibasic, 50; sodium chloride, 9.1; potassium citrate, 
monohydrate, 22; potassium sulfate, 5.2; manganous carbonate, 0.35; fer-
rous sulfate, heptahydrate, 0.5; ,"inc carbonate, O.lh; cupric carbonate, 
n.m; pota"ium iodate, O.OOh7; sodium selenite, pentahydrate. o.oomn: 
chromium potassium sulfate, dodecahydrate. O.045X; sucrose. finely pow-
dered, 12.h. The magnesium and calcium contents of the diet were assayed 
hy atomic ahsorption spectrophotometry and found tll he. in IllnlOl/kg diet: 
magnesium 2: calcium, 300. For Purina dog chow these values were: 
magnesium, 51: calciulll, 325. 
magnesium. The diet in three of these dogs was supple-
mented with 25 mmol of magnesium aspartate daily. This 
was hand-fed to the animals in a mixture with 2 ounces of 
dog food. These animals served as the "magnesium-sup-
plemented control group." Dogs fed the magnesium-sup-
plemented control diet and the magnesium-deficient diet 
were kept on their special diet for I 00 to 120 days before 
coronary occlusion. A third group of animals. the "chow-
fed control group." consisted of five female beagles that 
had been fed Purina laboratory chow all their lives. but that 
were introduced into the experimental protocol 4 weeks 
before surgery. For 4 weeks before termination of the ex-
periment. the chow-fed and magnesium-supplemented con-
trol groups were given subcutaneous injections of a mag-
nesium sulfate solution (509'( solution. 4 mllanimal) twice 
a week. Thus. both control groups were provided with a 
magnesium-sufficient diet throughout a 100 to 120 day pe-
riod. as well as parenteral magnesium supplements for 4 
weeks. before induction of myocardial infarction. 
Surgical procedure. Animals were lightly anesthetized 
with sodium thiamylal (0.2 mg/kg body weight). A blood 
sample was then drawn from the jugular vein. Chloralose 
(65 mg/kg) was injected intramuscularly for long-term main-
tenance of anesthesia, An endotracheal tube was inserted 
and mechanical ventilation initiated. Femoral artery and 
venous catheters were inserted for measurement of arterial 
pressure, withdrawal of blood during microsphere injection 
and intravenous injections. The left side of the chest was 
opened through the fourth intercostal space and the lung 
was retracted. A left atrial catheter was inserted for sub-
sequent microsphere injection. The left anterior descending 
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coronary artery was isolated and a length of umbilical tape 
placed around the artery immediately distal to the first di-
agonal branch. 
After the preocclusion electrocardiogram and blood 
pressure were recorded. the umbilical tape was pulled tight 
and approximately 20 million eerium-141-labeled tracer mi-
crospheres (15/Lm) were injected into the left atrium. With-
drawal of arterial blood through the femoral cannula was 
immediately initiated and continued for 2 minutes, Occlu-
sion was maintained for I hour. Heart rate. blood pressure 
and electrocardiogram were examined four or more times 
per hour and during episodes of ventricular tachycardia or 
fibrillation. Electrical cardioversion was performed as nec-
essary. using a superior vena cava catheter anode and an 
apical cup cathode. These electrodes were connected to a 
pulse gcnerator that delivered a 3 to 8 ms truncated pulse 
with a strength of I to 5 J. One hour after occlusion, a bolus 
of 0.75 mg of cyproheptadinium methiodide (\ 7) was in-
jected through the venous catheter and the coronary occlu-
sion was released to establish reperfusion. A maintenance 
dose of 0.75 mg of cyproheptadinium methiodide was given 
as an intravenous drip infusion over the first hour after 
reperfusion. Reperfusion was continued for 4 hours. Then 
the animals were killed by exsanguination. 
Quantitation of ischemic and infarcted myocar-
dium. After exsanguination. the heart was removed and 
immediately rinsed with 400 ml of saline solution at O°e. 
It was then placed at - noc for I hour. The atria were cut 
away and both ventricles were weighed. Transverse sec-
tions, 0.5 cm thick. were cut with an electric meat slicer. 
Slices were numbered consecutively, beginning at the apex. 
They were placed in a shallow tray. basal face up. Sections 
were stained with tetrazolium blue (I S) by the method of 
Schaper et al. (19) and Chambers et al. (20) to delineate 
early infarcted zones. Schaper et al. (19) have shown that 
this staining procedure is suitable for delineation of myo-
cardial infarcts produced by the method used here. After 
staining. the infarcted areas were identified by the clear 
boundary between the blue colored normal tissue and the 
nonstained infarcted areas. The infarcted areas were then 
painted with fluorescein so that they could be accurately 
delineated after freezing, The formozan-stained slices were 
then put between two acrylic plates. basal side up, in a 
prescribed numerical order. A flexible plastic sheet (Saran 
Wrap) was placed between one of the acrylic plates and the 
tissue slices. 
The acrylic plates were then pressed together in a plant 
press while spacers were used to hold the plates exactly 0.5 
cm apart. The entire plant press assembly and tissue slices 
were then stored at - 2rC overnight. The next day, the 
plant press was disassembled without disturbing the tissue 
slices. which adhered to only one face of the plastic sand-
wich. This was because the frozen tissue did not adhere to 
thc Saran Wrap that was present on one side. A sheet of 
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X-ray film (Kodak XAR-2), shielded from light in an opaque 
envelope, was placed over the tissue, and the previously 
removed acrylic plate was replaced. The sandwich of acrylic 
plates, film and tissue slices, held together by heavy clips, 
was returned to the freezer. 
After 24 hours of exposure, the film was removed and 
developed by standard procedures. The sections of ventric-
ular myocardium, still frozen on one acrylic plate, were now 
overlaid with a transparent acetate sheet. The outline of 
each section of ventricle, including the lumen, was traced 
onto this sheet. The area of necrosis, examined by ultraviolet 
light to bring out the fluorescein paint, was traced in a 
different color. The autoradiograph was used to trace the 
outline of the nonperfused portion of each ventricular slice 
onto the same acetate sheet. This resulted in a single sheet 
showing the outline of each ventricular slice as well as the 
area of ischemia and the area of necrosis. 
The volume of ischemic myocardium ("risk zone mass") 
and necrotic myocardium ("infarcted zone mass") were 
estimated by determining the surface area of each tissue 
slice involved in these processes. These area measurements 
were made with an Apple II computer equipped with a 
graphics tablet. Because each slice was 0.5 cm thick, each 
I cm2 of surface area represented 0.5 em' of muscle. Ad-
dition of the volume of ischemic and necrotic muscle for 
all slices gave the volumes affected by each process. The 
volume of the entire ventricular muscle mass was based on 
the weight of the right plus the left ventricle, using a specific 
gravity of 1.0 (the specific gravity of beagle dog ventricular 
myocardium was found to be 1.005 ± 0.02). 
The ratio of the infarcted zone mass to risk zone mass 
was then calculated. This ratio is a measure of the amount 
of necrosis per unit of ischemic myocardium. We refer to 
this as the "vulnerability index." 
Determination of blood flow rates. After determination 
of the infarcted zone mass and risk zone mass, a represen-
tative sample of each area was punched out with a cork 
borer, 0.5 em in diameter. This gave samples of 70 to 100 
mg wet weight. Samples of infarcted muscle were obtained 
from the center of the tetrazolium blue-differentiated areas. 
Samples of ischemic myocardium were obtained from isch-
emic tissue midway between the boundaries of the infarcted 
and normal tissue. Samples of tissue with "normal" flow 
were obtained from the left ventricular mid wall of the most 
basal section. These samples were weighted and placed in 
scintillation vials, and their cerium-141 content measured 
in a Packard 5120 gamma counter. Blood samples with-
drawn during surgery from the femoral artery were counted 
at the same time. Flow rates of each area were calculated 
in mllmin per g of tissue. 
Measurement of myocardial magnesium, calcium, so-
dium and potassium. At the time that the ventricles were 
sliced in preparation for tetrazolium staining, samples were 
taken for electrolyte determination. These samples were 
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always taken from the most basal section, which was totally 
free of ischemic or infarcted tissue. About 200 mg of left 
ventricular free wall myocardium was shredded and placed 
in a preweighed polyethylene vial. Wet ashing was carried 
out as previously described (21). This consisted of making 
repeated additions of 30% hydrogen peroxide while the vials 
were kept at 75°C and a stream of air was blown over the 
surface. After 8 hours of digestion the samples were brought 
to dryness and the residue extracted with 2 ml of 0.75 N 
nitric acid. The acid extracts were diluted for magnesium 
and calcium determinations in an IL357 atomic absorption 
spectrophotometer, and sodium and potassium determina-
tions in an IL443 flame photometer. This method of sample 
preparation and analysis, developed in our laboratory, gave 
recovery values of 98% or better for these four elements. 
Histology. A block of tissue adjacent to the area taken 
for electrolyte determinations was taken for histology to 
evaluate possible morphologic changes associated with 
magnesium deficiency. 
Results 
General observations on magnesium-deficient dogs. 
Dogs maintained on the magnesium-deficient diet were not 
obviously different from the magnesium-supplemented con-
trol animals insofar as their overt behavior or appearance 
was concerned. They did, however, show some evidence 
Figure I. Serum magnesium and calcium concentrations during 
the period of experimental diet administration. Open circles = 
serum magnesium (Mg) of magnesium-deficient dogs; open squares 
= serum magnesium of magnesium-supplemented dogs; closed 
circles = serum calcium (Ca) of magnesium-deficient dogs; closed 
squares == serum calcium of magnesium-supplemented dogs. 
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of increased irritability in that they tended to bark and move 
about more excitedly when disturbed than did the control 
animals. They also showed a prompt reduction in their mean 
serum magnesium level to 50% of the control value (Fig. 
I). This decrease occurred during the first 2 weeks on the 
deficient diet and was sustained for the remainder of the 
100 to 120 days on this diet. The serum calcium level was 
more erratic, but also decreased. In both the control and the 
experimental animals, the last serum sample taken for mag-
nesium and calcium determinations was obtained after thia-
mylal anesthetization and before surgery. These samples all 
showed the divalent cation-lowering effect described by 
Vormann et al. (22). 
Animals fed the magnesium-deficient diet lost about 10% 
of their body weight over the period of observation. whereas 
the deficient-supplemented control dogs maintained theirs 
(Table 2). This weight loss was not due to reduced intake, 
because animals in the deficient and the supplemented groups 
consumed all 400 g of the experimental diet fed to them 
daily. The final body weight of the chow-fed group was 
similar to that of the deficient-supplemented group. This 
group was kept by the supplier until 4 weeks before surgery. 
On arrival at our facility, they were started on Purina dog 
chow, and the series of magnesium sulfate injections was 
begun. Therefore, the body weights at the beginning of the 
100 day period were not observed. Body weights of this 
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group of animals were stable over the 4 week period of 
observation. 
Heart rate and blood pressure recorded during sur-
gery. The mean preocclusion heart rate was 179 ± 14 
beatslmin in the magnesium-deficient dogs and 126 ± 22 
per minute in the control dogs (p < 0.001). The respective 
blood pressures were 128/97 and 133/103 mm Hg (p = 
NS). The blood pressure and heart rate were examined per-
iodically throughout the surgical procedure and no signifi-
cant deviation from the preocclusion value was observed. 
During the surgical procedure, episodes of transient ven-
tricular fibrillation occurred once in each of two magnesium-
deficient animals at the time of occlusion. It also occurred 
in the same two animals and in an additional magnesium-
deficient dog at the time reperfusion was initiated. With the 
apical defibrillation cup prepositioned, ventricular fibrilla-
tion never lasted more than 5 seconds. Conversion to normal 
sinus rhythm was always achieved immediately. Fibrillation 
was never observed in the control animals. Episodes of 
tachycardia lasting less than 5 seconds were observed in 
both groups. There was no significant difference in the in-
cidence of such tachycardia between the groups. 
Measurement of electrolyte concentrations. Con-
centrations of magnesium, calcium, sodium and potassium 
in myocardium and bone are presented in Table 2. Myo-
cardial magnesium concentration did not vary with the di-
Table 2. Comparison of Age, Body Weight and Serum and Tissue Electrolytes of Dogs Fed Chow, Magnesium-Supplemented Diet 
and Magnesium-Deficient Diet 
Age (mo) 
Initial body weight (kg) 
Final body weight (kg) 
Magnesium 
Calcium 
Potassium 
Sodium 
Magnesium 
Calcium 
Potassium 
Sodium 
Ratio calcium/magnesium 
Ratio sodium/potassium 
Water (%) 
Magnesium 
Calcium 
Potassium 
Sodium 
Chow-Fed Control (n = 5) 
18.6 ± 7.4 
12.0 ± 1.5 
Mg-Supplemented (n = 3) 
16.0 ± 6.9 
10.4 ± 2.2 
10.5 :t 2.3 
Serum Electrolyte Content (mmoi/liter) at Surgery 
0.90 ± 0.10 
2.74 :t 015 
4.10 :t O.SO 
147 :t 6.9 
100 :t O.IS 
2.70 :t (Ul6 
4.0S :t 0.76 
149 :t 6.9 
Left Ventricular Electrolyte Content (mmol/kg wet weight) 
11.12 ± 0.52 
0.97 ± 0.12 
88.24 :t 3.68 
32.72 :t 2.41 
0.08 :t 0.005 
0.37 :t 0.04 
76.7:t 1.2 
11.12:t 0.32 
O.S5 :t 0.07 
92.07 :t 2.30 
2l\.~n :t 1.12 
(J.OS :t (J.OOS 
(U I :t (l.() I 
76.6 :t 0.2 
Bone Electrolyte Content (mmol/kg wet weight) 
122.6 :t 14 . .14 
4..198 :t 241 
17 :t 3.8 
216 :t 5.7 
115.6:t 16.44 
4.423 ± 217 
17 :t 2.6 
212 :t 1.3 
Mg-Deficient (n = 5) p Value* 
18.4 :t 11.7 NS 
13.5 :t 2.1 
12.2:tD1- NS 
0.56 :t 0.08 < 0.002 
2.56 :t (U4 NS 
4.Sl\ :t O.W NS 
145 :t 1.6 NS 
IO.S8 :t 0.50 NS 
1.0S :t 0.18 < 0.05 
89.08 :t 2.06 NS 
35.96 :t 1.l\9 < (l.(ll 
0.10 :t (l.(lIS < 0.01 
0.41 c': 0.03 < 0.02 
76.2 :t 1.3 NS 
96.0 ± 12.48 < 0.01 
4.396 ± 162 NS 
19 ± 3.S NS 
217 ± 10.1 NS 
*p values (t test) between the magnesium-deficient group and the combined animals in the two control groups; tsignificantly different from the initial 
weight, p < 0.02. Data are reported as mean :t I standard deviation. - = not measured. 
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Table 3. Myocardial Flow Rate Determined by Microsphere Technique Immediately After 
Coronary Ligation 
Control dogs (n = 8) 
Magnesium-deficient dogs (n = 5) 
Normal 
0.90 ± (U5 
0.X2 ± 0.21 
Flow Rate (ml/min per g) 
Ischemic p Value'" Infarcted p Valuet 
0.12 ± 0.06 (l.OOI 0.07 ± 0.06 < 0.001 
0.16 ± 0.D7 0.001 0.05 ± 0.04 < 0.001 
Significance level (t test) of difference in flow hetween normal and ischemic ("') and infarcted (i') myo-
cardium. There was no significant difference hetween any flow value in the control animals and the corresponding 
value in the experimental animals. The difference hetween the flow rates in the ischemic and infarcted muscle 
was also not significant. Data are reported as mean ± I standard deviation. 
etary magnesium levels. However, there were significant 
increases in myocardial levels of calcium (p < 0.05) and 
sodium (p < 0.01) in dogs that were fed the magnesium-
deficient diet. These increases in calcium and sodium con-
tent can also be identified by the increased values of the 
calcium/magnesium and sodiUm/potassium ratios. The in-
crease in tissue calcium content was not reflected in the 
histologic appearance. That is, microscopic examination of 
sections of myocardium from control as well as experimental 
dogs revealed no areas of calcification. In the bone, there 
was no difference in calcium, sodium or potassium content 
between the control and the magnesium-deficient groups. 
However, the magnesium content in bone of dogs fed the 
magnesium-deficient diet decreased 20% (p < 0.0 I) after 
100 days on the experimental diet. The two control groups 
(chow-fed and magnesium-supplemented animals), in ad-
dition to receiving similar dietary and parenteral amounts 
of magnesium over the course of the 100 to 120 day pre-
myocardial infarction period, were not significantly different 
in age, body weight, serum electrolyte concentrations or 
myocardial electrolyte content. Therefore, these two control 
groups were combined. 
Blood flow and infarct size measurement. Blood flow 
data, measured by determining the radioactivity generated 
by the cerium-141-labeled microspheres, are shown in Ta-
ble 3. Flow in the ischemic and infarcted zones was much 
less than in the "normal" zone (p < 0.001). The absolute 
values for these flow rates were similar for the magnesium-
deficient and control animals. 
A representative autoradioRraph of the heart sections, 
with the epicardial boundary hiRhliRhted, is shown in FiRure 
2a. The ischemic zone, or the "area at risk," is devoid of 
silver grains. This zone was primarily apical in all hearts 
studied. The risk zone boundary was traced onto the au-
toradiograph (Fig. 2b). The same tissue slice that was used 
for the autoradiograph shown in Figure 2a is shown after 
tetrazolium staining in Figure 2c. The dark surface of the 
tissue slice corresponds to the dark blue formozan precipitate 
on the surface in the noninfarcted area. The very pale zones 
in this figure correspond to the infarcted area. The right 
ventricular lumen is shown by the cross-hatched area, while 
the left ventricular lumen was compressed to a narrow slit 
in the center of the infarcted area and is omitted from these 
tracings. A composite tracing of Figure 2 a, band c, con-
taining ischemic and infarcted zones, is shown in Figure 
2d. Composite tracings such as this were prepared for all 
hearts and used for determination of risk zone mass and 
infarcted zone mass. 
Comparisons 0/ the infarcted zone mass, risk zone mass 
and the vulnerability index in experimental and control an-
imals arc shown in Table 4. The ventricular weight of the 
control and magnesium-deficient groups showed no signif-
icant difference. The infarcted zone mass is significantly 
greater in the magnesium-deficient group than in the control 
group. This was true of both the total amount of necrotic 
myocardium (p < 0.0 I) and the percent of the total ven-
tricular mass that was necrotic (p < 0.04). The vulnerability 
index was also significantly higher in the magnesium-
deficient group (p < 0.004). 
The reRression analysis of vulnerability index on serum 
maRnesium levels is shown in FiKure 3. It is obvious that, 
per unit of myocardium at risk, the amount of infarcted 
tissue decreases as serum magnesium increases. Relations 
were also found between myocardial calcium and sodium 
concentrations and vulnerability to infarction. The regres-
sion of the vulnerability index on myocardial sodium con-
centration is shown in Figure 4a. There is a positive cor-
relation between the elevated tissue sodium concentration 
and vulnerability to infarction after coronary occlusion 
(r = 0.78, P < 0.005). The regression of the vulnerability 
index on myocardial calcium is shown in Figure 4b. As 
with sodium, there is a positive correlation between tissue 
calcium concentration and vulnerability of the myocardium 
to infarction (r = 0.67, P < 0.01). 
Discussion 
Induction of magnesium deficiency. Several variables 
monitored during the experimental period to evaluate the 
magnesium nutritional status demonstrated the level of at-
tained deficiency. First, there was a significant decrease in 
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b 
d 
Figure 2. A representative ventricular section 
stained for differentiation of myocardial infarc-
tion and its corresponding autoradiograph to 
delineate ischemia. a, Autoradiograph after 24 
hours of exposure. b, Outline of ischemic area 
(dotted line). c, Tetrazolium blue stain, Pale 
area is the infarcted zone. d, Composite tracing 
of infarcted zone and ischemic zone, Hatched 
area outlines the right ventricular lumen. The 
left ventricular lumen, which is located at the 
center of the infarcted zone, is not shown be-
cause it was compressed to a narrow slit. 
Table 4. Comparison of Ventricular Weight and Sizes of Ischemic and Infarcted Zones in 
Control and Magnesium-Deficient Dogs 
Control Dogs Magnesium-Deficient 
(n 8) (n 5) p Value* 
Ventricle weight (g) 76.3 ±: 13.5 RHO ±: I \,1 NS 
Risk (ischemic) zone 
Mass (g) 13.'! ±: 5.5 17.2 ± 5.7 NS 
Percent total ventricle 17.'! ± 5.4 1'!.6 ± 5.6 NS 
Infarcted zone 
Mass (g) n ±: \.5 5.0 ± 1.7 < 0.01 
Percent total ventricle 3.1 ± \.9 5.8 ± 2.2 < 0.04 
Vulnerability indext 15.5 ± 70 29.3 ± 6.0 < 0.004 
*p values (I test) between control and experimental groups. No outliers were identified in either group of 
data by Chauvenet's criterion (24). -I'The vulnerability index is the ratio of the mass of myocardium actually 
made necrotic to the mass found to be ischemic multiplied by 100. The values shown here are the mean values 
of the animals in each group. This is not equal to the mean infarcted zone mass divided by the mean risk zone 
mass. Data are reported as mean ± I standard deviation. 
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Figure 3. Regression of vulnerability index (infarcted/ischemic 
myocardium X 100) on serum magnesium measured after 12 weeks 
on magnesium-deficient experimental diets. 
serum magnesium in the experimental dogs. Second, the 
magnesium content in bone decreased in dogs fed the mag-
nesium-deficient diet. Third, dogs on the magnesium-defi-
cient diet began to lose weight at about 70 days. An average 
Figure 4. Regression of vulnerability index (infarcted/ischemic 
myocardium x 100) on levels of sodium (a) and calcium (b) in 
the myocardium away from the ischemic zone. 
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loss of 10% of the initial body weight was observed after 
100 days on diet, in spite of food consumption equivalent 
to that of the control animals. Although all dogs were overtly 
in good health, these observqtions reflect and confirm that 
n~agnesium deficiency was indeed attained. In addition, the 
animals being depleted of magn~sium tended to bark and 
move abou( more excitedly when disturbed than did the 
control dogs. Although this is a subjective observation, it 
is a recognized feature of magnesium deficiency (23). 
Coronary blood flow. The microsphere studies showed 
that there was no difference in the volume of muscle per-
fused by the ligated artery in the experimental and control 
dogs. In addition, the amount of flow to the ischemic area 
was the same in both groups. Similarly, there was no dif-
ference in flow to the non ischemic muscle between these 
groups. Of course, the microsphere study only reflects the 
flow pattern at the time of occlusion, when the microspheres 
were injected. It is possible that differences in flow between 
the experimental and control groups occurred at a later time. 
If the difference in infarct size was due to postocclusion 
flow difference, then the observed deleterious effect of die-
tary magnesium deficiency could Qe attributed to perfusion 
effects alone. The most likely basis for such a postocclusion 
flow difference is either vasospasm related to magnesium 
deficiency (9-13) or decreased flow associated with ar-
rhythmia. Ventricular fibrillation was more common in the 
magnesium-deficient group. However, the episodes of ven-
tricular fibrillation were brief and dogs with ventricular fi-
brillation did not have a larger infarct than other magnesium-
deficient animals. That is. there were no outliers for infarct 
size according to the criterion of Chauvenet (24). Although 
a perfusion-related basis for the difference in vulnerability 
index cannot be ruled out, there is good reason to believe 
that the muscle of the magnesium-deficient dogs was met-
abolically altered to be more vulnerable to ischemic necro-
sis. Measurements of the myocardial cation concentrations 
showed that there were changes that could be expected to 
influence vulnerability to necrosis. 
Changes in electrolyte concentration. It is curious that 
the myocardial magnesium levels were similar in the ex-
perimental and control groups. Our measurements were made 
in the "normal" muscle, away from the ischemic zone. 
Although it is always possible that the occurrence of a myo-
cardial infarct might seriously alter such a variable, it seems 
reasonable to assume that equality of the myocardial mag-
nesium concentration existed before the coronary occlusion . 
This is especially so because Shen and Jennings (25) also 
observed that the magnesium cont~nt was similar in non-
infarcted tissues in myocardial infarcted and sham-operated 
dogs. Magnesium deficiency studies by Fischer and Giroux 
(26), using the rat model, also indicate that myocardial 
magnesium is maintained at the expense of bone magne-
sium. We had anticipated that any effect of dietary mag-
nesium on vulnerability to necrosis would be mediated by 
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a mechlinism involving the loss of intracellular magnesium. 
Such a pathogenesis is consistent with the observation that 
patients who die with an acute myocardial infarction show 
low levels of magnesium in the noninfarcted myocardium 
(5,6,27). We have no explanation for this difference be-
tween the findings in human subjects and experimental an-
imals. There is considerable variation in magnesium me-
tabolism and in the behavior of the magnesium parathyroid 
axis among species (28-30). The clinical implications of 
these differences are not known. It is possible, of course, 
that the diffetence is due to a pharmacologic agent. or some 
other therapeutic intervention. administered to either the 
animals or human subjects. 
Correilltions with mvocardial sodium and ('([Icium 11'1'-
els. Becau~e we did not find a decrease in myocardial mag-
nesium, the reduced serum magnesium can be viewed either 
as an index of an unknown biologic process involved in 
cellular necrosis or as a possible specific ti-igger of metabolic 
events of importance in such a process. Such specific met-
abolic events might be those that result in the increased 
myocardial levels of sodium and calcium. The changes in 
sodium and calcium are of importance for several reasons. 
First, the sodium and calcium levels covaried. suggesting 
that the variation was not due to random factors. Second. 
the magnitude of t.he change for both calcium and sodium 
correlated well with the vulnerability index. Third. not only 
is an increase in intracellular calcium and sodium widely 
accepted as evidence of cellular injury (31 ). but such elec-
trolyte changes have been implicated in the origin of myo-
cardial necrosis (32). Because myocardial calcification was 
not found on microscopic examination, we deduce that the 
increased myocardial calcium level was not due to dys-
trophic calcification. The parallel change in sodium supports 
this view. since dystrophic calcification would not be as-
sociated with a change in myocardial sodium levels. For 
these reasons. the observed increases in tissue calcium and 
sodium contribute to the etiology of myocardial injury. rather 
than being a consequence of such injury. 
Causes of increased myocardial calcium ([lid so-
dium. Because the changes in myocardial calcium ahd so-
dium associated with magnesium deficiency may be of im-
portance in the vulnerability to necrosis. it would he valuahle 
to know how they carne about. One possibility is through 
a hormonal effect. Thus, magnesium deficiency might result 
in an increase in parathyroid hormone production (26,33). 
Parathormone activity is known to be associated with ac-
cumulation of calcium by cardiac myocytes (34). Another 
possibility is that low extracellular magnesium levels. re-
flected in the lower serum magnesium concentration. affect 
the exterior of heart muscle cells. resulting in reduced ac-
tivity of sarcolemmal (sodium ion + potassium ion) aden-
osine triphosphatase I(Na' + K' )ATPasel. This would 
lead to elevated intracellular levels of sodium' and. through 
sodium/calcium exchange, of calcium ion as well (35). In 
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fact, reduction in dietary magnesium levels had been pre-
viously associated with reduced activity of myocardial (Na + 
+ K +)A TPase (36) _ The high myocardial sodium presum-
ably reflects an increase in intracellular sodium ion. This 
would result in a decrease in the resting potential (37), 
resulting in a reduction in the conduction velocity. Elevated 
intracellular calcium + + alters repolarization (38) and may 
decrease cell to cell coupling (39). These changes favor the 
occurrence of ventricular fibrillation (40), as was observed 
in these experiments. 
Other implications. The present experiments suggest 
that magnesium deficiency in dogs is associated with in-
creased myocardial vulnerability to ischemic necrosis. These 
experiments. however. were not designed to test the effects 
of magnesiuhl deficiency on vulnerability to arrhythmias or 
arterial spasm. Several studies have presented evidence sug-
gesting that magnesium deficiency can produce arterial spasm 
( 10-13) and cardiac arrhythmias ( 16,41 ). Complex changes 
in collateral flow after coronary occlusion could also play 
some role in the outcome of a coronary occlusive event of 
the type discussed here. Also important in this regard is the 
tachycardia found in the magnesium-deficient dogs. Tachy-
cardia can certainly predispose to a larger infarct (43,44) 
and could be a critical factor in the present findings. Not 
only did the magnesium-deficient animals have rapid heart 
rates. but there was some evidence that they were more 
prone to ventricular fibrillation than were control dogs. That 
is. there were more episodes of transient ventricular fibril-
lation in the experimental animals after coronary ligation. 
both before and during reperfusion. In contrast, ventricular 
fibrillation was not seen in any control animal. Thus, there 
arc many ways in which the circulatory system is at risk in 
magnesium deficiency. 
Clinical relevance. Although one must hesitate in draw-
ing clinical conclusions from animal experiments, it may 
be worthwhile to speculate on the clinical significance of our 
finding that magnesium-deficient dogs have larger infarcts 
than do control animals. There are three factors that could 
account for this finding: I) differences ih cardiac rhythm. 
2) differences in collateral flow due to vascular spasm in 
the deficient animals. and 3) differences in intracellular elec-
trolytes that might influence vulnerability to injury_ 
The magnesium-deficient dogs had a significant tachy-
cardia and showed a greater tendency to develop arrhyth-
mias. Epidemiologic studies show a correlation between 
water hardness and sudden death. An explahation of this 
finding may be that electrolyte imbalance secondary to in-
adequate mineral nutrition (5,6.27,45) may precipitate ar-
rhythmia (16,41,46) and sudden death. The results of the 
present study are consistent with such a hypothesis. The 
second factor. coronary artery spasm. is recognized more 
and more in the clinical syndrome of ischemia and infarc-
tion. Electrolytes such as calcium and magnesium playa 
significant role in the mechanism of spasm. which may be 
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the reason such patients respond well to calcium channel 
blocking agents. The third factor is somewhat elusive. The 
myocardial electrolyte abnormalities found in our experi-
mental animals have not been searched for in human beings. 
Should such electrolyte abnormalities occur in human beings, 
even to a much lesser degree than was found in the mag-
nesium-deficient dogs, they could be of great importance. 
All of the findings described in this report emphasize the 
role of electrolytes in cardiovascular injury. They show that 
the deficiency of even a single electrolyte can affect other 
electrolytes and have important consequences in cardiovas-
cular function and the pathogenesis of myocardial infarction. 
We are grateful to Jay Wiggins. PhD and Allan Ross. MD for critical 
reviews and numerous suggestions that improved this manuscript. and to 
Horace Brown for technical assistance. 
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